Continuing Education | Page 2 | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways

Community Practice Connections™: 19th Annual International Congress on the Future of Breast Cancer®

Sep 30, 2021

Accreditation/Credit Designation Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 2.0 Contact Hours. Acknowledgment of Support This activity is supported by educational grants from AstraZeneca; Daiichi Sankyo, Inc; Eisai Inc; Lilly; Novartis Pharmaceuticals Corporation; Pfizer Inc; Puma Biotechnology; and Seattle Genetics.

Enduring CME Activity: School of Breast Oncology® Live Video Webcast: Clinical Updates from San Antonio

Jan 30, 2021

Accreditation/Credit Designation Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 2.0 Contact Hours. Acknowledgment of Commercial Support This activity is supported by educational grants from AstraZeneca; Athenex; Daiichi Sankyo, Inc.; Foundation Medicine, Inc.; Genomic Health, Inc.; Merck & Co., Inc.; and Seattle Genetics, Inc.

School of Breast Oncology® Online Curriculum

Jan 31, 2021

Accreditation/Credit Designation Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 26.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 26.0 Contact Hours. Acknowledgment of Commercial Support This activity is supported by educational grants from AstraZeneca, Athenex, Daiichi Sankyo Inc., Genentech, Genomic Health, Lilly, MacroGenics Inc., Merck & Co Inc., Novartis Pharmaceuticals Corporation, and Pfizer. For further information concerning Lilly grant funding, visit lillygrantoffice.com.

Community Practice Connections™: Integrating Oral Chemotherapy Formulations in Breast Cancer Care

Sep 01, 2021

Accreditation/Credit Designation Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hours. Acknowledgment of Commercial Support This activity is supported by an educational grant from Athenex.

Burst CME™ for the Onco-Nurse: Optimizing Application of Targeted Therapies for HR+ Breast Cancer

Oct 15, 2021

Accreditation/Credit Designation Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 0.5 Contact Hours. Acknowledgment of Support This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

Navigating Treatment Options for HER2+ Breast Cancer Across the Disease Continuum: An Expert Tumor Board Discussion

Jan 08, 2022

Accreditation/Credit Designation Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Acknowledgment of Support This activity is supported by educational grants from AstraZeneca, Daiichi Sankyo, Inc, and Puma Biotechnology, Inc.

Oncology Briefings™: Highlights from San Antonio - Clinical Updates in Breast Cancer Care

Feb 28, 2021

Accreditation/Credit Designation Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Acknowledgment of Commercial Support This activity is supported by educational grants from AstraZeneca; Athenex; Daiichi Sankyo, Inc.; Foundation Medicine, Inc.; Genomic Health, Inc.; Merck & Co., Inc.; and Seattle Genetics, Inc.

Community Practice Connections™: 3rd Annual Precision Medicine Through Plasma™: Using Liquid Biopsies in Contemporary Oncology Care

Feb 28, 2021

Accreditation/Credit Designation Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hours. Acknowledgment of Commercial Support This activity is supported by educational grants from AstraZeneca, Foundation Medicine, Inc., Guardant Health, Inc., and Novartis Pharmaceuticals Corporation.

Clinical Vignette Series: 37th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow®

Jan 31, 2021

Accreditation/Credit Designation Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 2.0 Contact Hours. Acknowledgment of Commercial Support This activity is supported by educational grants from AbbVie Inc.; AstraZeneca; Athenex; Celgene Corporation; Daiichi Sankyo, Inc.; Eisai; Exelixis, Inc.; Genomic Health; Incyte Corporation; MacroGenics, Inc.; Novartis Pharmaceuticals Corporation; Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; Pfizer; Regeneron; Sanofi Genzyme; Seattle Genetics, Inc.; and Taiho Oncology, Inc.

Community Practice Connections™: Exploring Future Applications of HER2/3-Targeted Therapies Across Multiple Tumor Types

Aug 31, 2021

Accreditation/Credit Designation Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Acknowledgment of Commercial Support This activity is supported by an educational grant from Daiichi Sankyo Company, Ltd.

Virtual Tumor Board®: Global Perspectives on Comprehensive NGS Profiling to Personalize Treatment in Cancer

Aug 24, 2021

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Acknowledgment of Support This activity is supported by an educational grant from Illumina, Inc.

School of Breast Oncology® Live Video Webcast: Clinical Updates From Chicago

Sep 03, 2021

Accreditation/Credit Designation Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Acknowledgment of Commercial Support This educational activity is supported by educational grants from AstraZeneca, Bristol Myers Squibb, and Daiichi Sankyo, Inc.